Financials in USD. Standardized financial statements.
A compact view of how Asep Medical Holdings Inc turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Revenue? | $21,140 | $0 | $0 | $0 | $61,173 |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $134,880 | $155,401 | $177,177 | $26,451 | $55,013 |
| Gross Profit? | -$113,740 | -$155,401 | -$177,177 | -$26,451 | $6,160 |
| Gross Margin? | -538.0% | 0.0% | 0.0% | 0.0% | +10.1% |
| Operating Expenses? | $7.61M | $5.44M | $1.98M | $1,646 | $6,513 |
| Operating Income? | -$7.72M | -$5.44M | -$1.98M | -$28,097 | -$353 |
| EBITDA? | -$8.14M | -$3.33M | -$1.92M | $0 | $0 |
| Income Before Tax | -$9.43M | -$5.85M | -$2.34M | -$28,097 | -$353 |
| Income Tax Expense | $0 | -$89,100 | -$41,478 | $0 | $0 |
| Net Income? | -$8.23M | -$4.52M | -$2.20M | -$28,097 | -$353 |
| EPS? | $-0.13 | $-0.08 | $-0.04 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.13 | $-0.08 | $-0.04 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality